Corneal myofibroblast biology and pathobiology: Generation, persistence, and transparency

Experimental Eye Research

Volumn 99, Issue 1, 2012, Pages 78-88

  Wilson, Steven E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bone marrow derived cells; Cornea; Fibrocytes; Haze; Myofibroblast; Platelet derived growth factor; PRK; Stroma; Surface irregularity; Transforming growth factor ; Wound healing

Indexed keywords

INTEGRIN; INTERLEUKIN 1; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CORNEA CELL; CORNEAL MYOFIBROBLAST; CYTOKINE PRODUCTION; CYTOLOGY; CYTOPATHOLOGY; EXTRACELLULAR MATRIX; HUMAN; IN VITRO STUDY; MYOFIBROBLAST; NONHUMAN; PHOTOREFRACTIVE KERATECTOMY; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANIMALS; BONE MARROW CELLS; CORNEA; HUMANS; MYOFIBROBLASTS; PHOTOREFRACTIVE KERATECTOMY; PLATELET-DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84861689519     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.03.018     Document Type: Review

References (92)

1. Abe R., Donnelly S.C., Peng T., Bucala R., Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 2001, 166:7556-7562.
2. Bakhshayesh M., Soleimani M., Mehdizadeh M., Katebi M. Effects of TGF-β and b-FGF on the potential of peripheral blood-borne stem cells and bone marrow-derived stem cells in wound healing in a murine model. Inflammation 2012, 35:138-142.
3. Barbosa F.L., Chaurasia S., Cutler A., Asosingh K., Kaur H., de Medeiros F., Agrawal V., Wilson S.E. Corneal myofibroblast generation from bone marrow-derived cells. Exp. Eye Res. 2010, 91:92-96.
4. Barbosa F.L., Chaurasia S., Kaur H., de Medeiros F.W., Agrawal V., Wilson S.E. Stromal interleukin-1 expression in the cornea after haze-associated injury. Exp. Eye Res. 2010, 91:456-461.
5. Barbosa F.L., Lin M., Santhiago M.R., Singh V., Agrawal V., Wilson SE. Interleukin-1 receptor role in the viability of corneal myofibroblasts. Exp. Eye Res. 2012, 96:65-69.
6. Barry-Lane P.A., Wilson S.E., Cavanagh H.D., Petroll W.M., Jester J.V. Characterization of SV40-transfected cell strains from rabbit keratocytes. Cornea 1997, 16:72-78.
7. Barth P.J., Westhoff C.C. CD34+ fibrocytes: morphology, histogenesis and function. Curr. Stem Cell Res. Ther. 2007, 2:221-227.
8. Bellini A., Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab. Invest. 2007, 87:858-870.
9. Bhawan J., Majno G. The myofibroblast. Possible derivation from macrophages in xanthogranuloma. Am. J. Dermatopathol. 1989, 11:255-258.
10. Blumbach K., Zweers M.C., Brunner G., Peters A.S., Schmitz M., Schulz J.N., Schild A., Denton C.P., Sakai T., Fässler R., Krieg T., Eckes B. Defective granulation tissue formation in mice with specific ablation of integrin-linked kinase in fibroblasts - role of TGFβ1 levels and RhoA activity. J. Cell Sci. 2010, 123:3872-3883.
11. Bucala R., Spiegel L.A., Chesney J., Hogan M., Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1994, 1:71-81.
12. Carracedo S., Lu N., Popova S.N., Jonsson R., Eckes B., Gullberg D. The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. J. Biol. Chem. 2010, 285:10434-10445.
13. Carrington L.M., Albon J., Anderson I., Kamma C., Boulton M. Differential regulation of key stages in early corneal wound healing by TGF-beta isoforms and their inhibitors. Invest. Ophthalmol. Vis. Sci. 2006, 47:1886-1894.
14. Castano A., Lin S.L., Surowy T., Nowlin B.T., Turlapati S.A., Patel T., Singh A., Li S., Lupher M.L., Duffield J.S. Serum amyloid P inhibits fibrosis through FcgammaR-dependent monocyte/macrophage regulation in vivo. Sci. Transl. Med. 2009, 1:5-13.
15. Chaurasia S.S., Kaur H., Medeiros F.W., Smith S.D., Wilson S.E. Dynamics of the expression of intermediate filaments vimentin and desmin during myofibroblast differentiation after corneal injury. Exp. Eye Res. 2009, 89:133-139.
16. Davies M., Robinson M., Smith E., Huntley S., Prime S., Paterson I. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J. Cell Biochem. 2005, 95:918-931.
17. de Benito-Llopis L., Cañadas P., Drake P., Hernández-Verdejo J.L., Teus M.A. Keratocyte density 3 months, 15 months, and 3 years after corneal surface ablation with mitomycin C. Am. J. Ophthalmol. 2012, 153:17-23.
18. Direkze N.C., Forbes S.J., Brittan M., Hunt T., Jeffery R., Preston S.L., Poulsom R., Hodivala-Dilke K., Alison M.R., Wright N.A. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 2003, 21:514-520.
19. Fini M.E., Stramer B.M. How the cornea heals: cornea-specific repair mechanisms impacting on surgical outcomes. Cornea 2005, 24(Suppl. 8):S2-S11.
20. Funderburgh J.L., Funderburgh M.L., Mann M.M., Corpuz L., Roth M.R. Proteoglycan expression during transforming growth factor beta-induced keratocyte-myofibroblast transdifferentiation. J. Biol. Chem. 2001, 276:44173-44178.
21. Gao X., Li J., Huang H., Li X. Connective tissue growth factor stimulates renal cortical myofibroblast-like cell proliferation and matrix protein production. Wound Repair Regen. 2008, 16:408-415.
22. Garana R.M., Petroll W.M., Chen W.T., Herman I.M., Barry P., Andrews P., Cavanagh H.D., Jester J.V. Radial keratotomy. II. Role of the myofibroblast in corneal wound contraction. Invest. Ophthalmol. Vis. Sci. 1992, 33:3271-3282.
23. García-Olivas R., Hoebeke J., Castel S., Reina M., Fager G., Lustig F., Vilaró S. Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans. Histochem. Cell Biol. 2003, 120:371-382.
24. Grotendorst G.R., Smale G., Pencev D. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J. Cell Physiol. 1989, 140:396-402.
25. Guarino M., Tosoni A., Nebuloni M. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum. Pathol. 2009, 40:1365-1376.
26. Hashimoto N., Jin H., Liu T., Chensue S.W., Phan S.H. Bone marrow-derived progenitor cells in pulmonary fibrosis. J. Clin. Invest. 2004, 113:243-252.
27. Heindl L.M., Schlötzer-Schrehardt U., Cursiefen C., Bachmann B.O., Hofmann-Rummelt C., Kruse F.E. Myofibroblast metaplasia after descemet membrane endothelial keratoplasty. Am. J. Ophthalmol. 2011, 151:1019-1023.
28. Hills C.E., Squires P.E. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am. J. Nephrol. 2010, 31:68-74.
29. Hong K.M., Belperio J.A., Keane M.P., Burdick M.D., Strieter R.M. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 2007, 282:22910-22920.
30. Huh M.I., Chang Y., Jung J.C. Temporal and spatial distribution of TGF-beta isoforms and signaling intermediates in corneal regenerative wound repair. Histol. Histopathol. 2009, 24:1405-1416.
31. Huh M.I., Kim Y.H., Park J.H., Bae S.W., Kim M.H., Chang Y., Kim S.J., Lee S.R., Lee Y.S., Jin E.J., Sonn J.K., Kang S.S., Jung J.C. Distribution of TGF-beta isoforms and signaling intermediates in corneal fibrotic wound repair. J. Cell Biochem. 2009, 108:476-488.
32. Ishizaki M., Guang Z., Haseba T., Shafer S.S., Kao W.W.Y. Expression of collagen I, smooth muscle a-actin, and vimentin during the healing of alkali burned and lacerated corneas. Invest. Ophthalmol. Vis. Sci. 1993, 34:3320-3328.
33. Jester J.V., Barry P.A., Lind G.J., Petroll W.M., Garana R., Cavanagh H.D. Corneal keratocytes: in situ and in vitro organization of cytoskeletal contractile proteins. Invest. Ophthalmol. Vis. Sci. 1994, 35:730-743.
34. Jester, J.V., Brown, D., Pappa, A., Vasilou, V. Myofibroblast differentiation modulates keratocyte crystallin protein expression, concentration and cellular light scattering. Invest. Ophthalmol. Vis. Sci., in press.
35. Jester J.V., Ho-Chang J. Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp. Eye Res. 2003, 77:581-592.
36. Jester J.V., Huang J., Barry-Lane P.A., Kao W.W., Petroll W.M., Cavanagh H.D. Transforming growth factor (beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest. Ophthalmol. Vis. Sci. 1999, 40:1959-1967.
37. Jester J.V., Huang J., Petroll W.M., Cavanagh H.D. TGF beta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGF beta, PDGF and integrin signaling. Exp. Eye Res. 2002, 75:645-657.
38. Jester J.V., Moller-Pedersen T., Huang J., Sax C.M., Kays W.T., Cavangh H.D., Petroll W.M., Piatigorsky J. The cellular basis of corneal transparency: evidence for 'corneal crystallins'. J. Cell Sci. 1999, 112:613-622.
39. Jester J.V., Petroll W.M., Barry P.A., Cavanagh H.D. Temporal, 3-dimensional, cellular anatomy of corneal wound tissue. J. Anat. 1995, 186:301-311.
40. Kaji Y., Soya K., Amano S., Oshika T., Yamashita H. Relation between corneal haze and transforming growth factor-beta1 after photorefractive keratectomy and laser in situ keratomileusis. J. Cataract Refract. Surg. 2001, 27:1840-1846.
41. Karamichos D., Guo X.Q., Hutcheon A.E., Zieske J.D. Human corneal fibrosis: an in vitro model. Invest. Ophthalmol. Vis. Sci. 2010, 51:1382-1388.
42. Karamichos D., Hutcheon A.E., Zieske J.D. Transforming growth factor-β3 regulates assembly of a non-fibrotic matrix in a 3D corneal model. J. Tissue Eng. Regen. Med. 2011, 5:e228-e238.
43. Kaur H., Chaurasia S.S., Agrawal V., Wilson S.E. Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta-1. Exp. Eye Res. 2009, 89:152-158.
44. Kaur H., Chaurasia S.S., Agrawal V., Wilson S.E. Expression of PDGF receptor-alpha in corneal myofibroblasts in situ. Exp. Eye Res. 2009, 89:432-434.
45. Kaur H., Chaurasia S.S., de Medeiros F.W., Agrawal V., Salomao M.Q., Singh N., Ambati B.K., Wilson S.E. Corneal stroma PDGF blockade and myofibroblast development. Exp. Eye Res. 2009, 88:960-965.
46. Kawakita T., Espana E.M., He H., Li W., Liu C.Y., Tseng S.C. Intrastromal invasion by limbal epithelial cells is mediated by epithelial-mesenchymal transition activated by air exposure. Am. J. Pathol. 2005, 167:381-393.
47. Kawakita T., Espana E.M., He H., Hornia A., Yeh L.K., Ouyang J., Liu C.Y., Tseng S.C. Keratocan expression of murine keratocytes is maintained on amniotic membrane by down-regulating transforming growth factor-beta signaling. J. Biol. Chem. 2005, 280:27085-27092.
48. Kawashima M., Kawakita T., Higa K., Satake Y., Omoto M., Tsubota K., Shimmura S., Shimazaki J. Subepithelial corneal fibrosis partially due to epithelial-mesenchymal transition of ocular surface epithelium. Mol. Vis. 2010, 16:2727-2732.
49. Kim W.-J., Mohan R.R., Mohan R.R., Wilson S.E. Effect of PDGF, IL-1 alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea. Invest. Ophthalmol. Vis. Sci. 1999, 40:1364-1372.
50. Kuo I.C., Lee S.M., Hwang D.G. Late-onset corneal haze and myopic regression after photorefractive keratectomy (PRK). Cornea 2004, 23:350-355.
51. LaGier A.J., Yoo S.H., Alfonso E.C., Meiners S., Fini M.E. Inhibition of human corneal epithelial production of fibrotic mediator TGF-β2 by basement membrane-like extracellular matrix. Invest. Ophthalmol. Vis. Sci. 2007, 48:1061-1071.
52. Li D.Q., Lee S.B., Tseng S.C. Differential expression and regulation of TGF-beta1, TGF-beta2, TGF-beta3, TGF-betaRI, TGF-betaRII and TGF-betaRIII in cultured human corneal, limbal, and conjunctival fibroblasts. Curr. Eye Res. 1999, 19:154-161.
53. Lipshitz I., Loewenstein A., Varssano D., Lazar M. Late onset corneal haze after photorefractive keratectomy for moderate and high myopia. Ophthalmology 1997, 104:369-373.
54. Liu S., Xu S.W., Blumbach K., Eastwood M., Denton C.P., Eckes B., Krieg T., Abraham D.J., Leask A. Expression of integrin beta1 by fibroblasts is required for tissue repair in vivo. J. Cell Sci. 2010, 123:3674-3682.
55. Luttrull J.K., Smith R.E., Jester J.V. In vitro contractility of avascular corneal wounds in rabbit eyes. Invest. Ophthalmol. Vis. Sci. 1985, 26:1449-1452.
56. Maltseva O., Folger P., Zekaria D., Petridou S., Masur S.K. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest. Ophthalmol. Vis. Sci. 2001, 42:2490-2495.
57. Masur S.K., Conors R.J., Cheung J.K., Antohi S. Matrix adhesion characteristics of corneal myofibroblasts. Invest. Ophthalmol. Vis. Sci. 1999, 40:904-910.
58. Masur S.K., Dewal H.S., Dinh T.T., Erenburg I., Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:4219-4223.
59. McGhee C.N., Bryce I.G. Natural history of central topographic islands following excimer laser photorefractive keratectomy. J. Cataract Refract. Surg. 1996, 22:1151-1158.
60. Mohan R.R., Hutcheon A.E.K., Choi R., Hong J.-W., Lee J.-S., Mohan R.R., Ambrósio R., Zieske J.D., Wilson S.E. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp. Eye Res. 2003, 76:71-87.
61. Mohan R.R., Stapleton W.M., Sinha S., Netto M.V., Wilson S.E. A novel method for generating corneal haze in anterior stroma of the mouse eye with the excimer laser. Exp. Eye Res. 2008, 86:235-240.
62. Møller-Pedersen T., Cavanagh H.D., Petroll W.M., Jester J.V. Corneal haze development after PRK is regulated by volume of stromal tissue removal. Cornea 1998, 17:627-639.
63. Møller-Pedersen T., Cavanagh H.D., Petroll W.M., Jester J.V. Neutralizing antibody to TGF beta modulates stromal fibrosis but not regression of photoablative effect following PRK. Curr. Eye Res. 1998, 17:736-747.
64. Nagy Z.Z., Hiscott P., Seitz B., Shlötzer-Schrehardt U., Simon M., Süveges I., Naumann G.O. Ultraviolet-B enhances corneal stromal response to 193-nm excimer laser treatment. Ophthalmology 1997, 104:375-380.
65. Nakamura H., Siddiqui S.S., Shen X., Malik A.B., Pulido J.S., Kumar N.M., Yue B.Y. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Mol. Vis. 2004, 10:703-711.
66. Netto M.V., Mohan R.R., Medeiros F.W., Dupps W.J., Sinha S., Krueger R.R., Stapleton W.M., Rayborn M., Suto C., Wilson S.E. Femtosecond laser and microkeratome LASIK flaps: comparative effects on wound healing and inflammatory infiltration. J. Ref. Surg. 2007, 23:667-676.
67. Netto M.V., Mohan R.R., Sinha S., Sharma A., Dupps W., Wilson S.E. Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp. Eye Res. 2006, 82:788-797.
68. Netto M.V., Mohan R.R., Sinha S., Sharma A., Gupta P.C., Wilson S.E. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, proliferation, haze, and keratocyte density. J. Ref. Surg. 2006, 22:562-574.
69. Paralkar V.M., Vukicevic S., Reddi A.H. Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: implications for development. Dev. Biol. 1991, 143:303-308.
70. Petridou S., Maltseva O., Spanakis S., Masur S.K. TGF-beta receptor expression and Smad2 localization are cell density dependent in fibroblasts. Invest. Ophthalmol. Vis. Sci. 2000, 41:89-95.
71. Petroll W.M., Cavanagh H.D., Jester J.V. Assessment of stress fiber orientation during healing of radial keratotomy wounds using confocal microscopy. Scanning 1998, 20:74-82.
72. Quan T.E., Cowper S.E., Bucala R. The role of circulating fibrocytes in fibrosis. Curr. Rheumatol. Rep. 2006, 8:145-150.
73. Raviv T., Majmudar P.A., Dennis R.F., Epstein R.J. Mytomycin-C for post-PRK corneal haze. J. Cataract Refract. Surg. 2000, 26:1105-1106.
74. Reneker L.W., Bloch A., Xie L., Overbeek P.A., Ash J.D. Induction of corneal myofibroblasts by lens-derived transforming growth factor beta1 (TGFbeta1): a transgenic mouse model. Brain Res. Bull. 2010, 2010(81):287-296.
75. Saika S., Yamanaka O., Sumioka T., Okada Y., Miyamoto T., Shirai K., Kitano A., Tanaka S. Transforming growth factor beta signal transduction: a potential target for maintenance/restoration of transparency of the cornea. Eye Contact Lens 2010, 36:286-289.
76. Santhiago M.R., Singh V., Barbosa F.L., Agrawal V., Wilson S.E. Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits. Exp. Eye Res. 2011, 93:786-789.
77. Sharma A., Mehan M.M., Sinha S., Cowden J.W., Mohan R.R. Trichostatin a inhibits corneal haze in vitro and in vivo. Invest. Ophthalmol. Vis. Sci. 2009, 50:2695-2701.
78. Singh, V., Agrawal, V., Santhiago, M.R., Wilson, S.E., 2012. Stromal fibroblastebone marrow-derived cell interactions: implications for myofibroblast development in the cornea. Exp. Eye Res., 23;98C: 1-8. [Epub ahead of print].
79. Singh V., Santhiago M.R., Barbosa F.L., Agrawal V., Singh N., Ambati B.K., Wilson S.E. Effect of TGFβ and PDGF-B blockade on corneal myofibroblast development in mice. Exp. Eye Res. 2011, 93:810-817.
80. Stramer B.M., Zieske J.D., Jung J.C., Austin J.S., Fini M.E. Molecular mechanisms controlling the fibrotic repair phenotype in cornea: implications for surgical outcomes. Invest. Ophthalmol. Vis. Sci. 2003, 44:4237-4246.
81. Strieter R.M., Keeley E.C., Hughes M.A., Burdick M.D., Mehrad B. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J. Leukoc. Biol. 2009, 86:1111-1118.
82. Tandon A., Tovey J.C., Sharma A., Gupta R., Mohan R.R. Role of transforming growth factor Beta in corneal function, biology and pathology. Curr. Mol. Med. 2010, 10:565-578.
83. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
84. Tuli S.S., Liu R., Chen C., Blalock T.D., Goldstein M., Schultz G.S. Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation. Curr. Eye Res. 2006, 31:709-719.
85. Waddington S.N., Crossley R., Sheard V., Howe S.J., Buckley S.M., Coughlan L., Gilham D.E., Hawkins R.E., McKay T.R. Gene delivery of a mutant TGFβ3 reduces markers of scar tissue formation after cutaneous wounding. Mol. Ther. 2010, 18:2104-2111.
86. Willis B.C., duBois R.M., Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc. Am. Thorac. Soc. 2006, 3:377-382.
87. Wilson S.E., Chaurasia S.S., Medeiros F.W. Apoptosis in the initiation, modulation and termination of the corneal wound healing response. Exp. Eye Res. 2007, 85:305-311.
88. Wilson S.E., Mohan R.R., Hutcheon A.E.K., Mohan R.R., Ambrósio R., Zieske J.D., Hong J.W., Lee J.-S. Effect of ectopic epithelial tissue within the stroma on keratocyte apoptosis, mitosis, and myofibroblast transformation. Exp. Eye Res. 2003, 76:193-201.
89. Wilson S.E., Mohan R.R., Netto M.V., Perez V., Possin D., Huang J., Kwon R., Alekseev A. RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing. Invest. Ophthalmol. Vis. Sci. 2004, 45:2201-2211.
90. Wilson S.E., Salomao M.Q. Corneal molecular and cellular biology update for the refractive surgeon. J. Ref. Surg. 2009, 25:459-466.
91. Wilson S.E., Schultz G.S., Chegini N., Weng J., He Y.-G. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp. Eye Res. 1994, 59:63-72.
92. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.